Mesenchymal stem cells explained: Quality, Safety & Source | Dr. Anthony Oliva

Not all mesenchymal stem cells are produced, characterized, or expanded in the same way—and those differences matter.

In this Regen Summit 2026 presentation, neuroscientist and regenerative medicine researcher Dr. Anthony Oliva discusses what healthcare professionals should understand when evaluating mesenchymal stem cells, or MSCs. He examines cell sourcing, GMP manufacturing, culture passage, senescence, physiological responsiveness, and the differences between autologous and allogeneic cells.

Dr. Oliva also explores how MSC research intersects with inflammation, vascular aging, exosomes, healthspan, and neurological research. These applications remain areas of active investigation and should be understood within the appropriate clinical and regulatory context.

Have questions about training or course options? Leave a comment below or visit https://myinjectiontraining.com/ to learn more.

Our content is for informational purposes only and should not be treated as medical or health advice. Please consult with your doctor/healthcare provider if you have any questions about your medical condition.

#MesenchymalStemCells #RegenerativeMedicine #RegenSummit